We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Consortium Identifies Osteoporosis Drug as Possible COVID-19 Treatment
EU Consortium Identifies Osteoporosis Drug as Possible COVID-19 Treatment
A European Union-backed research consortium has identified raloxifene, an osteoporosis drug, as a possible treatment for mildly symptomatic COVID-19 patients.